inflammation

New therapeutic frontiers for Multiple Sclerosis

From personal experience I have been able to verify that in recent years Multiple Sclerosis (MS) increasingly affects early onset, therefore very young people, but I have also been able to appreciate, having worked in a Research and Treatment Center for Multiple Sclerosis, that State-of-the-art therapies visually slow its progression, thus also increasing the quality… Continua a leggere New therapeutic frontiers for Multiple Sclerosis

2022-12-28Marketing

Gene therapy and rheumatoid arthritis

There has been talk of gene therapy recently (see ADA-SCID) and it continues to be talked about. There is no longer a scientific journal that does not report advances or results obtained in the experimentation of these techniques. Gene therapy is not a new approach but tangible results are only now beginning to be appreciated.… Continua a leggere Gene therapy and rheumatoid arthritis

2022-12-28Marketing